Who owns MAPLIGHT THERAPEUTICS INC COM?
- Ticker: MPLT
- CUSIP Number: 56565p103
Tip: Access positions for across all investors
Analyze quarterly positions in Maplight Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Maplight Therapeutics stock
Who bought or sold MAPLIGHT THERAPEUTICS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management | 2.8M | $49M | 100% | Dec 2025 |
|
| Goldman Sachs Group | 1.9M | $34M | 100% | Dec 2025 |
|
| Vanguard Group | 870k | $15M | 100% | Dec 2025 |
|
| Geode Capital Management | 389k | $6.8M | 100% | Dec 2025 |
|
| State Street Corporation | 230k | $4.0M | 100% | Dec 2025 |
|
| Lazard Asset Management | 208k | $3.6M | 100% | Dec 2025 |
|
| Freestone Grove Partners | 184k | $3.2M | 100% | Dec 2025 |
|
| Bnp Paribas Investment Partners | 148k | $2.6M | 100% | Dec 2025 |
|
| Charles Schwab Investment Management | 138k | $2.4M | 100% | Dec 2025 |
|
| Marshall Wace | 40k | $697k | 100% | Dec 2025 |
|
| TD Asset Management | 37k | $649k | 100% | Dec 2025 |
|
| Bank of New York Mellon | 36k | $630k | 100% | Dec 2025 |
|
| Barclays | 26k | $464k | 100% | Dec 2025 |
|
| Wells Fargo & Company | 19k | $328k | 100% | Dec 2025 |
|
| UBS Group | 18k | $321k | 100% | Dec 2025 |
|
| Rhumbline Advisers | 14k | $240k | 100% | Dec 2025 |
|
| Walleye Trading Advisors | 12k | $205k | 100% | Dec 2025 |
|
| New York State Common Retirement Fund | 5.3k | $93k | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 3.5k | $61k | 100% | Dec 2025 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 3.0k | $53k | 100% | Dec 2025 |
|
| Legal & General Group | 1.6k | $29k | 100% | Dec 2025 |
|
| Sterling Capital Management | 519.00 | $9.1k | 100% | Dec 2025 |
|
| Farther Finance Advisors | 120.00 | $2.1k | 100% | Dec 2025 |
|